# Study of Radspherin® in Recurrent Ovarian Cancer Subjects With Peritoneal Carcinomatosis

> **NCT03732768** · PHASE1 · COMPLETED · sponsor: **Oncoinvent Solutions AS** · enrollment: 21 (actual)

## Conditions studied

- Peritoneal Carcinomatosis
- Ovarian Cancer

## Interventions

- **DRUG:** Radspherin

## Key facts

- **NCT ID:** NCT03732768
- **Lead sponsor:** Oncoinvent Solutions AS
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-08
- **Primary completion:** 2025-09-30
- **Final completion:** 2025-09-30
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2026-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03732768

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03732768, "Study of Radspherin® in Recurrent Ovarian Cancer Subjects With Peritoneal Carcinomatosis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03732768. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*